Article Dans Une Revue Leukemia & lymphoma Année : 2025

The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia

Résumé

in this review, we focus on the pro-oncogene MYc, the modes of deregulation in mouse and human B-cells, its undisputable importance in the evaluation of biological prognostication of patients, but also how it impacts on response to modern therapeutics, and how it should be targeted to improve the overall survival of chronic lymphocytic lymphoma (cll) patients. After an overview of the current understanding of the molecular dysregulation of c-MYc, we will show how cll, both in its indolent and transformed phases, has developed among other B-cell lymphomas a tight regulation of its expression through the chronic activation of B-cell Receptors (among others). this is particularly important if one desires to understand the mechanisms at stake in the over-expression of c-MYc especially in the lymph nodes compartment. So doing, we will show how this oncogene orchestrates pivotal cellular functions such as metabolism, drug resistance, proliferation and histologic transformation (Richter syndrome).

Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-04869741 , version 1 (07-01-2025)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Loic Ysebaert, Pierre-Luc Mouchel, Camille Laurent, Anne Quillet-Mary. The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia. Leukemia & lymphoma, 2025, pp.1 - 13. ⟨10.1080/10428194.2024.2447362⟩. ⟨inserm-04869741⟩
13 Consultations
2 Téléchargements

Altmetric

Partager

More